Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5480]

Enhancing breast cancer care through AI and collaboration

Dr Gabrielle Speijer, Dr Fernando Suarez and Dr Tolga Ozmen

Enhancing breast cancer care through AI and collaboration ( Dr Gabrielle Speijer, Dr Fernando Suarez and Dr Tolga Ozmen )

NSCLC brain metastases: TTFields after SRS delays intracranial progression...

Dr Vinai Gondi - Northwestern Medicine West Region and Proton Center, Illinois...

NSCLC brain metastases: TTFields after SRS delays intracranial progression without affecting QoL ( Dr Vinai Gondi - Northwestern Medicine West Region and Proton Center, Illinois, USA )

Apalutamide and salvage radiotherapy benefits luminal B subtype prostate cancer

Prof Daniel Spratt - University Hospitals Cleveland Medical Center, Cleveland...

Apalutamide and salvage radiotherapy benefits luminal B subtype prostate cancer ( Prof Daniel Spratt - University Hospitals Cleveland Medical Center, Cleveland, USA )

ctDNA testing improves detection of treatable metastases compared to standard...

Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA

ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer ( Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA )

ADT with PORT is a good treatment option for men with unfavourable intermediate...

Dr Mack Roach III - University of California San Francisco, San Francisco, USA

ADT with PORT is a good treatment option for men with unfavourable intermediate risk or favourable high risk PC ( Dr Mack Roach III - University of California San Francisco, San Francisco, USA )

Non-clear cell renal cell carcinoma: Management of papillary RCC

Prof Camillo Porta and Prof Laurence Albiges

Non-clear cell renal cell carcinoma: Management of papillary RCC ( Prof Camillo Porta and Prof Laurence Albiges )

Bladder cancer updates from the first half of 2025

Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone...

Bladder cancer updates from the first half of 2025 ( Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone and Dr Benjamin Pradere )

Improving efficacy and toxicity reporting - and treatment insights from an...

Dr Ross Camidge - University of Colorado School of Medicine, Aurora, Colorado

Improving efficacy and toxicity reporting - and treatment insights from an oncologist patient ( Dr Ross Camidge - University of Colorado School of Medicine, Aurora, Colorado )

CURB phase II trial: Tumour burden predicts survival after SBRT in NSCLC...

Dr Matthew McMillan - Memorial Sloan-Kettering Cancer Center, New York, USA

CURB phase II trial: Tumour burden predicts survival after SBRT in NSCLC oligoprogression ( Dr Matthew McMillan - Memorial Sloan-Kettering Cancer Center, New York, USA )

WCLC 2025: Latest in EGFR positive NSCLC

Prof Enriqueta Felip, Dr Antonio Passaro, Dr Alex Spira and Prof Ignacio Gil...

WCLC 2025: Latest in EGFR positive NSCLC ( Prof Enriqueta Felip, Dr Antonio Passaro, Dr Alex Spira and Prof Ignacio Gil-Bazo )

Dose escalation of RG6344 demonstrates safety and promising activity in BRAF...

Dr Maria Vieito - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Dose escalation of RG6344 demonstrates safety and promising activity in BRAF V600E solid tumours ( Dr Maria Vieito - Vall d'Hebron Institute of Oncology, Barcelona, Spain )

Treatment management of favourable risk and very favourable risk patients

Dr Guillermo de Velasco and Dr Marco Maruzzo

Treatment management of favourable risk and very favourable risk patients ( Dr Guillermo de Velasco and Dr Marco Maruzzo )

More from ecancer